Department of Surgery, Vascular and Endovascular Surgery, University Hospital, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
Department of Surgery, Vascular and Endovascular Surgery, University Hospital, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
Eur J Vasc Endovasc Surg. 2014 Sep;48(3):258-65. doi: 10.1016/j.ejvs.2014.05.020. Epub 2014 Jul 2.
To report experience with the concept of temporary aneurysm sac perfusion (TASP) and second stage side branch completion to prevent severe spinal cord ischemia (SCI) after branched endovascular aortic repair (bEVAR) for thoracoabdominal aortic aneurysm (TAAA).
Patients were treated for TAAA with bEVAR between January 2009 and September 2012. TASP was performed by non-completion of side branches to one of the reno-visceral arteries, distal aortic or iliac extensions with secondary side branch completion. Primary endpoints of the study were overall technical success, side branch patency, perioperative mortality, and the rate of severe SCI.
Eighty-three patients were treated for TAAA with branched aortic stent grafts with (n = 40) or without (n = 43) TASP. Overall technical success, including aneurysm exclusion, absence of persistent type I or III endoleak, TASP side branch patency, and secondary side branch completion was 35/40 (88%). Secondary TASP side branch completion was performed after a median of 48 days (range 1-370 days). The rate of early re-interventions for reno-visceral side branch complications was 8/283 (3%) and 6/83 (7%) for perioperative mortality, with three patients in both groups. Severe SCI or paraplegia was observed in 11/83 (13%) of the patients and reduced in the TASP group (2/40) compared with the non-TASP group (9/43; p = .03), especially in Crawford I-III aneurysms (1/29 vs. 7/24; p = .01). However, one TASP patient died 4 months after bEVAR during the TASP interval from suspected aorto-bronchial fistula.
The concept of TASP after bEVAR for TAAA is feasible and seems to reduce the risk of SCI. Early side TASP branch completion within 4 weeks is recommended to reduce the risk of rupture, although, according to the individual clinical presentation, a longer TASP interval might improve neurological rehabilitation from SCI.
报告分支型腔内主动脉修复术(bEVAR)治疗胸腹主动脉瘤(TAAA)后采用临时动脉瘤囊灌注(TASP)和二期分支完成技术预防严重脊髓缺血(SCI)的经验。
2009 年 1 月至 2012 年 9 月,对 TAAA 患者进行 bEVAR 治疗。通过对其中一个肾-内脏动脉、主动脉远端或髂外支的分支未完成,实现 TASP,并对侧支进行二期完成。本研究的主要终点是总体技术成功率、侧支通畅率、围手术期死亡率和严重 SCI 发生率。
83 例 TAAA 患者接受了分支型主动脉覆膜支架植入治疗,其中(n=40)采用 TASP,(n=43)未采用 TASP。包括动脉瘤隔绝、无持续性Ⅰ型或Ⅲ型内漏、TASP 侧支通畅率和二期侧支完成率在内的总体技术成功率为 35/40(88%)。二期 TASP 侧支完成时间中位数为 48 天(范围 1-370 天)。肾-内脏侧支并发症的早期再介入率为 8/283(3%),围手术期死亡率为 6/83(7%),两组各有 3 例患者。11/83(13%)的患者出现严重 SCI 或截瘫,TASP 组(2/40)明显低于非 TASP 组(9/43;p=0.03),尤其是 Crawford I-III 型动脉瘤(1/29 与 7/24;p=0.01)。然而,1 例 TASP 患者在 bEVAR 后 4 个月死于疑似主-支气管瘘的 TASP 期间。
TAAA 患者 bEVAR 后 TASP 的概念是可行的,似乎可以降低 SCI 的风险。建议在 4 周内尽早完成二期 TASP 分支,以降低破裂风险,但根据患者个体临床表现,延长 TASP 间隔时间可能会改善 SCI 后的神经康复。